Entrar Registro gratuito

AMAG Pharmaceuticals Venda descoberta % de circulação

Qual é o Venda descoberta % de circulação de AMAG Pharmaceuticals?

O Venda descoberta % de circulação de AMAG Pharmaceuticals, Inc. é 38.03%

Qual é a definição de Venda descoberta % de circulação?



Porcentagem de venda de ações descobertas em circulação é a quantidade de ações que estão sendo vendidas descobertas comparada com a circulação de ações totais, expressa como uma porcentagem.

Short percentage of float, or short interest ratio, is calculated by taking the total amount of shares shorted and dividing it by the total amount of shares available for trade. It is an indirect metric of investor sentiment. When short percentage of float is high, above 40%, it implies company investors hope shares will decline in value. The percentage is used by both fundamental and technical traders to identify trends. The short percentage of float can also be calculated for entire exchanges to determine the sentiment of the market as a whole. If it is high of around five or greater for an exchange, this can be taken as a bearish signal, and vice versa.

Venda descoberta % de circulação de empresas na Setor Health Care em NASDAQ em comparação com AMAG Pharmaceuticals

O que AMAG Pharmaceuticals faz?

AMAG Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. Its products include Intrarosa, Vyleesi, Makena, CBR, Feraheme, and MuGard. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.

Empresas com venda descoberta % de circulação semelhantes a AMAG Pharmaceuticals